CNBC Halftime Report
2026-08-20 · Hosted by Scott Wapner · CNBC
Executive Summary
Stocks rose as the Treasury's move to double long-dated bond buybacks pulled the 30-year yield back from above 5.30%, easing pressure that had been building across markets. Joe Terranova described a rotation out of momentum, memory, and semiconductor names into healthcare and energy, while Kevin Simpson likened the intervention to the Fed's 2011 Operation Twist and called it bullish for equities and earnings. Brenda "Bryn" Talkington pointed to a robust corporate earnings backdrop — 51.6% Q2 growth, with 29% and 26.5% projected for Q3 and Q4 — as the reason markets weren't rattled by the earlier yield backup.
Key Stories & Changes
1. Treasury Buyback and Yield Relief Rally
30-year yield had traded above 5.30% the prior day; Treasury's move to double long-end buybacks brought relief across the curve
Joe Terranova described continued rotation: capital "coming out of" momentum, memory, and semiconductors and moving into healthcare and energy
Kevin Simpson compared the move favorably to the 2011 Operation Twist, calling it bullish for equities, while cautioning that neither the Treasury nor the Fed can fully control the long end of the curve
Bryn Talkington cited 51.6% Q2 earnings growth (with roughly 20 points attributable to a handful of AI names), and forward estimates of 29% (Q3) and 26.5% (Q4) growth as the reason markets were not overly rattled by rising yields
2. Moderna-Merck Cancer Vaccine Milestone
MRNA: Moderna — Nearly doubled (~+180%) — First Phase 3 win for personalized cancer vaccine platform validates mRNA beyond respiratory use
MRK: Merck — New high — Keytruda combination could extend franchise relevance ahead of 2028 patent cliff
CNBC's Annika Kim Constantino reported the trial met its primary goal of reducing melanoma recurrence/spread versus Keytruda alone
Kevin Simpson (Merck holder) called it validation of "an entirely new way to tackle cancer" and noted Merck's revenue growth challenge (low single digits over three years) had weighed on the stock despite strong momentum
Merck trading near 55x earnings was flagged as rich for a company growing revenue at roughly 3%
3. Marvell-Google Custom Chip Deal
Marvell shares surged nearly 10% after Google secured an option to buy a $12.2 billion stake as part of a custom chip partnership
Joe Terranova (a Marvell holder) explained the majority of the ~59 million shares involved are contingent on Alphabet's future silicon purchases
Terranova confirmed continued portfolio rotation from IBM into Alphabet, trimming IBM further after a post-earnings slide earlier this year that triggered initial selling around July 4th
4. OpenAI vs. Anthropic Widening Gap
WSJ reported OpenAI's Q2 operating loss grew to $12.3 billion (from ~$9 billion in Q1), with revenue just under $7 billion, up only 18% quarter-over-quarter
Anthropic reportedly generated $11.5 billion in the quarter on an EBITDA-profitable basis; annualized revenue run-rate near $65 billion versus OpenAI's roughly $40 billion
CNBC's Kate Rooney noted more recent (July) data showed some improvement — OpenAI's July revenue growth reportedly 20%, enterprise growth 32% — per commentary from Jim Cramer and OpenAI president Greg Brockman
Both companies are now on file to go public with the SEC, intensifying direct comparison
5. Energy Sector's Record Run
XLE (energy sector ETF) hit an eighth straight positive day, driven by refined product margins (the "3-2-1 crack spread," which measures crude-to-gasoline/diesel refining profit) at all-time highs
Damage to Russian refineries from Ukrainian strikes cited as a contributing factor
Joe Terranova favors refiners (Valero, Philip 66) on positioning/sentiment but flagged valuations are getting stretched, comparing it to the memory trade's late-June setup; Brenda Talkington remains long energy broadly across public and private holdings
6. Gold and Precious Metals Momentum
Gold coming off its worst day since late July, but Wells Fargo reiterated a $4,900 2026 price target
Options activity showed GLD calls outpacing puts nearly 3-to-1 on 2.5x average volume; Bitcoin-tracking IBIT saw similarly bullish options flow
Liz Young Thomas turned newly bullish on gold, citing renewed central bank demand tied to geopolitical tension rather than just yields
7. Tom Lee's Updated Stock Picks
Added JPMorgan and Arista Networks to his core stock ideas list; named Robinhood a stock to avoid in 2026
Panelists broadly agreed with JPMorgan and Arista (an AI networking holding for Joe Terranova)
Split on Robinhood: Kevin Simpson defended it citing 32% revenue growth and record net assets; Brenda Talkington, who sold in June, agreed with Lee that it remains overly correlated to crypto
8. Home Improvement Retail: Lowe's and Home Depot
Lowe's delivered a muted outlook, reinforcing a "frozen" housing market narrative discussed the prior day
Kevin Simpson (a Home Depot holder) said Home Depot's numbers exceeded his expectations, with strong professional/contractor sales and no guidance cut, though the stock trades at a higher multiple than Lowe's
Trends Identified
1. Treasury Intervention as Bullish Signal, Not Panacea
Panelists broadly welcomed the Treasury's yield-capping move as supportive for equities in the near term, drawing parallels to the Fed's 2011 Operation Twist. However, several noted the long end of the curve cannot be fully controlled by policy, and a hawkish Fed signal at Jackson Hole could reignite a "tug of war" between fiscal and monetary authorities.
2. Earnings Strength Overrides Rate Anxiety
Robust and broadening corporate earnings growth — hitting 11 of 11 sectors in the most recent reporting season — is functioning as the primary buffer against yield-related market stress. This earnings cushion is why panelists were not alarmed by the prior day's yield spike despite its magnitude.
3. Healthcare/Biotech Emerges as the Year's Patience Trade
The Moderna-Merck breakthrough exemplifies a broader pattern in biotech investing: long stretches of flat performance followed by outsized payoffs on clinical catalysts, as seen previously with Eli Lilly's GLP-1 (diabetes/obesity drug) run and Revolution Medicines' pancreatic cancer data. Panelists see this rotation into healthcare as more durable than last year's brief, short-lived rotation.
4. AI Financial Scrutiny Intensifies Ahead of Dual IPOs
With both OpenAI and Anthropic now on file with the SEC, the widening gap in growth, losses, and margin profile is becoming central to how investors assess AI infrastructure risk broadly. The comparison is increasingly framed as a referendum on which company's business model — consumer-led versus enterprise-led — will prove more durable.
5. Energy's Persistent Strength Despite Lower Crude
Energy sector strength is increasingly decoupled from spot crude prices, driven instead by refining margins and longer-dated oil futures. This divergence suggests structural tightness in refined product supply rather than pure crude price speculation. ---
Sentiment Analysis
Overall Market Sentiment: Constructive, Rotation-Driven
The committee expressed broad optimism supported by strong earnings, though tempered by acknowledgment of unresolved fiscal and AI-financing risks.
Risk Factors Highlighted
Fiscal-monetary policy tug of war: A hawkish Fed Chair Worsh comment at Jackson Hole could reverse the Treasury-driven yield relief.
AI capex financing risk: Widening OpenAI losses raise questions about the durability of AI infrastructure spending assumptions.
Merck valuation stretch: Trading near 55x earnings against roughly 3% revenue growth, even after the vaccine catalyst.
Energy sector positioning risk: Terranova compared crowded refiner positioning to the "memory trade" setup that later reversed.
Housing market freeze: Lowe's muted outlook signals continued weakness tied to elevated mortgage rates.
Robinhood's crypto correlation: Panel disagreement over whether Robinhood's valuation remains excessively tied to volatile crypto sentiment.
Canada-US trade negotiation uncertainty: A social media post from Canadian PM Mark Carney touting favorable terms risked complicating ongoing tariff talks, per Bloomberg's Eamon Javers reporting from Washington.
Debt ceiling risk in 2026: Panelist Barry Nap-style concerns (raised elsewhere in the broader macro conversation) about a potential debt ceiling clash post-midterms complicating fiscal policy.
This episode was covered in today's [The Market Signal — 2026-08-20](https://marketsignal.beehiiv.com/p/the-market-signal-2026-08-20), a cross-source synthesis of multiple podcast reports.